Phase I study of TT-00420, a multiple kinase inhibitor, as a single agent in advanced solid tumors.

JOURNAL OF CLINICAL ONCOLOGY(2021)

引用 6|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要